Page 87 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
Pósteres
PETHEMA
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
Congresos internacionales
• P1702: Impact of center characteristics and macroeconomic factors on the outcome of adult patients with acute lymphoblastic leukemia treated with pediatric-inspired protocols. 27th Congress of the European Hematology Association (EHA). EHA2022 Hybrid Viena (Jun 9-17).
Barba P, Morgades M, Montesinos P, González Campos J, Torrent A, Gil C, Bernal T, Tor- mo M, Mercadal S, Saumell S, García-Cadenas I, Queipo de Llano M, Cervera M, Coll R, Bermúdez A, Amigo M, Monsalvo S, Esteve J, García Boyero R, Novo A, Hernández Rivas J, Cladera A, Martínez-Sánchez P, Serrano J, Artola MT, Soria B, Abella E, Vall-Llobera F, Bergua J, Herrera P, Barrios D, Ribera JM .
Grupo de trabajo coautor: LAL .
• ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leu- kemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treat- ment and Survival.
10th Society of Hematologic Oncology (SOHO) Annual Meeting 2022. Hybrid event, 28 Sep-01 Oct 2022.
Ribera J, Granada I, González T, Morgades M, Sánchez R, Such E, Barrena S, Ciudad J, Soriano B, Benito R, Avetisyán G, Lumbreras E, Miguel C, Santos S, Zamora L, Mallo M, Genescà E, González C, Lopes T, Hernández-Rivas JM, Orfao A, Ribera JM .
Grupo de trabajo coautor: LAL .
• PB1762 Ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL): PhALLCON study.
27th Congress of the European Hematology Association (EHA). EHA2022 Hybrid Viena (Jun 9-17).
Jabbour E, Martinelli G, Vignetti M, Kantarjian H, Gómez-Almaguer D, Minami Y, Dombret H, Hennessy M, Vorog A, Wang B, Ribera JM .
Grupo de trabajo coautor: LAL .
• IKZF1 Deletions Are Markers of Treatment Resistance in Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia Patients Treated within the Ongoing Risk-Adapted Pethema LAL19 Trial.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
87